Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:investor
|
| gptkbp:affiliatedWith |
gptkb:University_College_London
|
| gptkbp:country |
gptkb:United_Kingdom
|
| gptkbp:focusesOn |
commercialization of UCL research
|
| gptkbp:investedIn |
engineering
life sciences physical sciences early-stage technology biomedical innovations |
| gptkbp:launched |
2016
|
| gptkbp:location |
gptkb:London
|
| gptkbp:managedBy |
gptkb:AlbionVC
|
| gptkbp:notableInvestment |
gptkb:MeiraGTx
gptkb:SomaServe gptkb:Freeline_Therapeutics gptkb:Orchard_Therapeutics |
| gptkbp:provides |
seed funding
series A funding |
| gptkbp:supports |
spinouts from UCL
|
| gptkbp:website |
https://www.ucltf.co.uk/
|
| gptkbp:bfsParent |
gptkb:Storm_Therapeutics
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
UCL Technology Fund
|